LOCATION MEDICALE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LOCATION MEDICALE
Largest movements
- Cash +€16,801
up €16,801 (+292.8%), from €5,739 to €22,540
mainly Advances received (+€16,207) and Trade debts (+€9,059)
- Tangible fixed assets +€5,473
new in 2025: €5,473
- Receivables within one year +€2,487
up €2,487 (+34.7%), from €7,169 to €9,656
of which Other amounts receivable: +€2,925
- Advances received +€16,207
new in 2025: €16,207
- Trade debts +€9,059
up €9,059 (+49.3%), from €18,369 to €27,428
- Tax, wage and social debts -€806
no longer reported in 2025 (was €806)
- Other operating charges -€541
down €541 (-97.7%), from €554 to €13
- Staff costs +€217
new in 2025: €217
- Financial charges +€212
up €212 (+214.1%), from €99 to €311
- Financial income +€198
new in 2025: €198
- Depreciation +€27
new in 2025: €27
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €19,186 | €43,947 | +€24,761 | +129.1% |
| Fixed assets | 21/28 | - | €5,473 | +€5,473 | |
| Tangible fixed assets | 22/27 | - | €5,473 | +€5,473 | |
| Furniture and vehicles | 24 | - | €5,473 | +€5,473 | |
| Current assets | 29/58 | €19,186 | €38,474 | +€19,288 | +100.5% |
| Amounts receivable within one year | 40/41 | €7,169 | €9,656 | +€2,487 | +34.7% |
| Trade receivables | 40 | €1,692 | €1,254 | -€438 | -25.9% |
| Other amounts receivable | 41 | €5,477 | €8,402 | +€2,925 | +53.4% |
| Cash at bank and in hand | 54/58 | €5,739 | €22,540 | +€16,801 | +292.8% |
| Deferred charges and accrued income | 490/1 | €6,278 | €6,278 | = | 0.0% |
| Total equity and liabilities | 10/49 | €19,186 | €43,947 | +€24,761 | +129.1% |
| Equity | 10/15 | €11 | €312 | +€301 | +2736.4% |
| Profit (loss) carried forward | 14 | €11 | €312 | +€301 | +2736.4% |
| Amounts payable | 17/49 | €19,175 | €43,635 | +€24,460 | +127.6% |
| Amounts payable within one year | 42/48 | €19,175 | €43,635 | +€24,460 | +127.6% |
| Trade debts | 44 | €18,369 | €27,428 | +€9,059 | +49.3% |
| Suppliers | 440/4 | €18,369 | €27,428 | +€9,059 | +49.3% |
| Advances received on contracts in progress | 46 | - | €16,207 | +€16,207 | |
| Taxes, remuneration and social security | 45 | €806 | - | -€806 | |
| Taxes | 450/3 | €806 | - | -€806 | |
| Remuneration, social security and pensions | 62 | - | €217 | +€217 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €27 | +€27 | |
| Other operating charges | 640/8 | €554 | €13 | -€541 | -97.7% |
| Gross operating margin | 9900 | €664 | €671 | +€7 | +1.1% |
| Operating profit (loss) | 9901 | €110 | €414 | +€304 | +276.4% |
| Financial income | 75/76B | - | €198 | +€198 | |
| Recurring financial income | 75 | - | €198 | +€198 | |
| Financial charges | 65/66B | €99 | €311 | +€212 | +214.1% |
| Recurring financial charges | 65 | €99 | €311 | +€212 | +214.1% |
| Profit (loss) for the period before taxes | 9903 | €11 | €301 | +€290 | +2636.4% |
| Profit (loss) for the period | 9904 | €11 | €301 | +€290 | +2636.4% |
| Profit (loss) for the period to be appropriated | 9905 | €11 | €301 | +€290 | +2636.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.